These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36994010)

  • 1. Dyslipidemia in youth: Epidemiology, pathophysiology, screening, management, and treatment: A review of the literature.
    Esfarjani SV; Zakerkish M
    J Family Med Prim Care; 2022 Dec; 11(12):7519-7526. PubMed ID: 36994010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia in pediatrician's practice.
    Burlutskaya AV; Tril VE; Polischuk LV; Pokrovskii VM
    Rev Cardiovasc Med; 2021 Sep; 22(3):817-834. PubMed ID: 34565080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Heart Federation Cholesterol Roadmap 2022.
    Ray KK; Ference BA; Séverin T; Blom D; Nicholls SJ; Shiba MH; Almahmeed W; Alonso R; Daccord M; Ezhov M; Olmo RF; Jankowski P; Lanas F; Mehta R; Puri R; Wong ND; Wood D; Zhao D; Gidding SS; Virani SS; Lloyd-Jones D; Pinto F; Perel P; Santos RD
    Glob Heart; 2022; 17(1):75. PubMed ID: 36382159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?
    Vrablik M; Corsini A; Tůmová E
    Curr Atheroscler Rep; 2022 Mar; 24(3):161-169. PubMed ID: 35174437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
    Chapman MJ; Zamorano JL; Parhofer KG
    Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and Management of Dyslipidemia in Children and Adolescents.
    Schefelker JM; Peterson AL
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Czech atherosclerosis society guidelines for the diagnosis and treatment of dyslipidemia in adults].
    Vaverková H; Soska V; Rosolová H; Ceska R; Cífková R; Freiberger T; Pit'ha J; Poledne R; Stulc T; Urbanová Z; Vráblík M; Czech Atherosclerosis Society
    Cas Lek Cesk; 2007; 146(6):II-XV. PubMed ID: 17650596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Practice Recommendations for Pediatric Dyslipidemia.
    Elkins C; Fruh S; Jones L; Bydalek K
    J Pediatr Health Care; 2019; 33(4):494-504. PubMed ID: 31227123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia and Cardiovascular Risk in Children and Adolescents.
    Mainieri F; La Bella S; Chiarelli F
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dyslipidemia and obesity 2011. Similarities and differences].
    Ceska R; Vrablík M; Sucharda P
    Vnitr Lek; 2011 Mar; 57(3):248-53. PubMed ID: 21495405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Essence of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version and Treatment Guide for Dyslipidemia 2013--Current Strategy for the Lipid Assessment].
    Arai H
    Rinsho Byori; 2014 Sep; 62(9):878-83. PubMed ID: 27526533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
    Wong ND; Budoff MJ; Ferdinand K; Graham IM; Michos ED; Reddy T; Shapiro MD; Toth PP
    Am J Prev Cardiol; 2022 Jun; 10():100335. PubMed ID: 35342890
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.